TON - March 2018, Vol 11, No 1

New Criteria for Inherited Prostate Cancer Genetic Testing

Similar to other disease sites, prostate cancer has seen a surge in genetic testing options. To help address the role of genetic testing in prostate cancer disease management, the NCCN Clinical Practice Guidelines in Oncology were updated in February 2018 to include germline recommendations.

Read More ›

Humanizing Cancer Care: The Patient Perspective

At the ACCC National Oncology Conference in October 2017, Brianne Joseph, LPI, brought the audience to their feet with a compelling message for those involved in cancer care.

Read More ›

Quizartinib Combinations Show High Activity in Newly Diagnosed Acute Myeloid Leukemia with FLT3 Mutation

The combination of the investigational drug quizartinib plus azacitidine (Vidaza) or low-dose cytarabine has substantial activity in patients with myeloid leukemias and FLT3 mutations.

Read More ›

Congratulations to the 2017 ONE Award Winner!

We are proud to announce that the winner of the 2017 ONE Award is Laura Mulderrig, BSN, RN, OCN, a nurse in the clinical research unit at Fox Chase Cancer Center in Philadelphia.

Read More ›

From The Editor - TON March 2018

In this issue, we feature a profile of the Taussig Cancer Center, Cleveland Clinic, OH, where, in my capacity as a nurse practitioner in the Department of Hematologic Oncology and Blood Disorders, my primary role is to diagnose and manage patients with multiple myeloma, amyloidosis, and other hematologic disorders.

Read More ›

Combining Immunotherapy and Radiotherapy Shows Good Synergy

As the number of patients receiving immune checkpoint blockade grows, the combination of radiation and immunotherapy has become increasingly relevant, particularly in the palliative care setting, where radiation therapy is used to treat painful lesions or brain metastases.

Read More ›

Measuring Financial Well-Being in Cancer Survivorship

To effectively address socioeconomic disparities in healthcare, it is critical that we improve our understanding of the material, psychosocial, and behavioral dimensions of financial well-being, said Reginald D. Tucker-Seeley, MA, ScM, ScD, at the 2017 AACR Science of Cancer Health Disparities Conference.

Read More ›

Noteworthy Numbers: Cervical Cancer

Although it is very curable when found and treated early on, early-stage cervical cancer may not cause any noticeable signs or symptoms. In advanced stages, however, the disease may cause vaginal bleeding or discharge that is abnormal for the patient.1

Read More ›

Silent Patients Find Their Voices Through an Advocate’s Journey

Advocacy usually begins with personal crisis and the need for support, but it eventually moves on to sharing experiences and information with others, speaking out in public forums, and working to influence change, suggested Musa Mayer, breast cancer survivor and advocate, at the recent ESMO International Consensus Conference for Advanced Breast Cancer in Lisbon, Portugal.

Read More ›

Beth Faiman, PhD, APRN-BC, AOCN, is an author, presenter, and educator on the topics of multiple myeloma, general cancer diagnosis and treatment, and management of skeletal and other cancer-related complications.

Read More ›

Page 1 of 2

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: